Compartment-specific expression and function of the chemokine IP-10/CXCL10 in a model of renal endothelial microvascular injury

被引:79
作者
Panzer, Ulf
Steinmetz, Oliver M.
Reinking, Ruediger R.
Meyer, Tobias N.
Fehr, Susanne
Schneider, Andre
Zahner, Gunther
Wolf, Gunter
Helmchen, Udo
Schaerli, Patrick
Stahl, Rolf A. K.
Thaiss, Friedrich
机构
[1] Univ Hamburg, Krankenhaus Eppendorf, Inst Pathol, D-2000 Hamburg, Germany
[2] Univ Hamburg, Krankenhaus Eppendorf, Med Klin 4, D-2000 Hamburg, Germany
[3] Zentrum Mol Neurobiol, Hamburg, Germany
[4] Univ Klin Jena, Innere Med Klin 3, Jena, Germany
[5] Harvard Univ, Sch Med, Dept Pathol, CBR Inst Biomed Res, Boston, MA 02115 USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2006年 / 17卷 / 02期
关键词
D O I
10.1681/ASN.2005040364
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The recruitment of inflammatory cells into renal tissue, mainly T cells and monocytes, is a typical feature of various renal diseases such as glomerulonephritis, thrombotic angiopathies, allograft rejection, and vasculitis. T cells predominantly infiltrate the tubulointerstitium, whereas monocytes are present in the tubulointerstitial and glomerular compartment. Because chemokines play a pivotal role in leukocyte trafficking under inflammatory conditions, this study investigated whether a differential expression of chemokines contributes to the precise coordination of leukocyte subtype trafficking in a rat model of renal microvascular endothelial injury. Renal microvascular endothelial injury was induced in rats by selective renal artery perfusion with an anti-endothelial antibody. Induction of the disease led to severe glomerular and tubulointerstitial endothelial injury with subsequent upregulation of chemokines followed by inflammatory cell recruitment. Among the analyzed chemokine mRNA, IP-10/CXCL10 (119-fold), acting via CXCR3 on activated T cells, and MCP-1/CCL2 (65-fold), acting via CCR2 on monocytes, were by far the most strongly upregulated chemokines. In situ hybridization revealed that IP-10/CXCL10 mRNA was selectively expressed by endothelial cells in the tubulointerstitial area, co-localizing with infiltrating T cells. Despite extensive damage of glomerular vasculature, no IP-10/CXCL10 expression by glomerular endothelial cells was detected. MCP-1/CCL2 mRNA in contrast was detectable in the glomerulus and the tubulointerstitium. Treatment with a neutralizing anti-IP-10/CXCL10 antibody significantly reduced the number of infiltrating tubulointerstitial T cells without affecting monocyte migration and led to an improved renal function. Our study demonstrates a role of IP-10/CXCL10 on T cell recruitment in a rat model of renal endothelial microvascular injury. Furthermore, a differential chemokine expression profile by endothelial cells in different renal compartments was found. These findings are consistent with the hypothesis that functional heterogeneity of endothelial cells from different vascular sites exists and provide an insight into the molecular mechanisms that may mediate compartment-specific T cell and monocyte recruitment in inflammatory renal disease.
引用
收藏
页码:454 / 464
页数:11
相关论文
共 32 条
[1]   Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice [J].
Anders, HJ ;
Belemezova, E ;
Eis, V ;
Segerer, S ;
Vielhauer, V ;
De Lema, GP ;
Kretzler, M ;
Cohen, CD ;
Frink, M ;
Horuk, R ;
Hudkins, KL ;
Alpers, CE ;
Mampaso, F ;
Schlöndorff, D .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (06) :1504-1513
[2]   Chemokines and chemokine receptors are involved in the resolution or progression of renal disease [J].
Anders, HJ ;
Vielhauer, V ;
Schlöndorff, D .
KIDNEY INTERNATIONAL, 2003, 63 (02) :401-415
[3]   Mig and IP-10: CXC chemokines that target lymphocytes [J].
Farber, JM .
JOURNAL OF LEUKOCYTE BIOLOGY, 1997, 61 (03) :246-257
[4]   IFN-inducible protein-10 has a differential role in podocyte during Thy 1.1 glomerulonephritis [J].
Han, GD ;
Koike, H ;
Nakatsue, T ;
Suzuki, K ;
Yoneyama, H ;
Narumi, S ;
Kobayashi, N ;
Mundel, P ;
Shimizu, F ;
Kawachi, H .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (12) :3111-3126
[5]   Chemokines as therapeutic targets in renal disease [J].
Holdsworth, SR ;
Kitching, AR ;
Tipping, PG .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2000, 9 (05) :505-511
[6]   Chemokines: therapeutic targets for autoimmune and inflammatory renal disease [J].
Kelley, VR ;
Rovin, BH .
SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2003, 24 (04) :411-421
[7]   Multiple facets of macrophages in renal injury [J].
Kluth, DC ;
Erwig, LP ;
Rees, AJ .
KIDNEY INTERNATIONAL, 2004, 66 (02) :542-557
[8]   Heterogeneity of endothelial cells from different organ sites in T-cell subset recruitment [J].
Lim, YC ;
Garcia-Cardena, G ;
Allport, JR ;
Zervoglos, M ;
Connolly, AJ ;
Gimbrone, MA ;
Luscinskas, FW .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (05) :1591-1601
[9]   Chemokines: multiple levels of leukocyte migration control [J].
Moser, B ;
Wolf, M ;
Walz, A ;
Loetscher, P .
TRENDS IN IMMUNOLOGY, 2004, 25 (02) :75-84
[10]  
Murphy PM, 2000, PHARMACOL REV, V52, P145